AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ALFA AMYLASE

11 registrations across 3 African markets— 11 active

Markets with ALFA AMYLASE

Recent registrations

Brand / ProductMarketHolderStatusExpires
BIOMYLASE
SOLUTION BUVABLE
🇲🇦Moroccoactive
MEGAMYLASE
comprimé enrobé / 3000 U.CEIP
🇸🇳SenegalBIOCODEXactive
MAXILASE
COMPRIME ENROBE
🇲🇦Moroccoactive
MEGAMYLASE Alfa-amylase 3000 CP(2 X 12) FRILAB SA
comprimé enrobé à 3000U
🇲🇬MadagascarFRILAB S.A.active
BIOMYLASE
COMPRIME ENROBE
🇲🇦Moroccoactive
BIOMYLASE
SUSPENSION BUVABLE
🇲🇦Moroccoactive
MAXILASE
SOLUTION BUVABLE
🇲🇦Moroccoactive
MEGAMYLASE Alfa-amylase 3000 CP(2 X 12) FRILAB SA
comprimé enrobé à 3000U
🇲🇬MadagascarFRILAB S.A.active
BIOMYLASE
COMPRIME ENROBE
🇲🇦Moroccoactive
BIOMYLASE
SUSPENSION BUVABLE
🇲🇦Moroccoactive
BIOMYLASE
SOLUTION BUVABLE
🇲🇦Moroccoactive

ALFA AMYLASE in Africa — Regulatory Overview

ALFA AMYLASE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Madagascar, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.